Search

Showing "11155" results for ""

IAS: Daily aciclovir doesn't reduce HIV risk in HSV-2-infected women - was poor adherence the reason?

IAS: HPV therapeutic vaccine stimulates immune response in people with HIV

IAS: PEP following sexual assault in Kenya and Thailand - more awareness and follow-up necessary

IAS: Studies present reassuring data on the use of ART in patients on TB treatment

IAS: Integrase inhibitor raltegravir (MK-0518) potent, durable and more tolerable than efavirenz in treatment-naive at 48 weeks

IAS: Regular viral load testing essential for patients in resource limited settings on NNRTIs, says US resistance expert

IAS: Hepatitis C clusters reveal international transmission among HIV-positive gay men

IAS: Novel once-daily CCR5 antagonist, INC9471, appears potent, well tolerated after 14 days monotherapy

IAS: Aciclovir treatment doesn't significantly reduce HIV or HSV-2 shedding in genital secretions

IAS: Vicriviroc still effective at 48 weeks in treatment-experienced, but relationship with cancer remains uncertain

IAS: ART interruption particularly unsafe for HIV-positive patients coinfected with hepatitis B or C

IAS: Low rates of HIV transmission in breastfeeding women on ART

IAS: Circumcision may be acceptable to some gay men, but study says no value for HIV prevention

IAS: Screening for B*5701 reduces abacavir hypersensitivity incidence to zero

IAS: Models predict costs and benefits of circumcision programmes

IAS: Penile washing after sex not a substitute for circumcision

IAS: Regular dietician consultation effective at preventing HAART-associated dyslipidaemia

IAS: Cardiovascular disease and diabetes increasing as causes of death for people with HIV in Brazil

Receive the latest HIV research and conference news

Showing "11155" results for ""

IAS: Daily aciclovir doesn't reduce HIV risk in HSV-2-infected women - was poor adherence the reason?

IAS: HPV therapeutic vaccine stimulates immune response in people with HIV

IAS: PEP following sexual assault in Kenya and Thailand - more awareness and follow-up necessary

IAS: Studies present reassuring data on the use of ART in patients on TB treatment

IAS: Integrase inhibitor raltegravir (MK-0518) potent, durable and more tolerable than efavirenz in treatment-naive at 48 weeks

IAS: Regular viral load testing essential for patients in resource limited settings on NNRTIs, says US resistance expert

IAS: Hepatitis C clusters reveal international transmission among HIV-positive gay men

IAS: Novel once-daily CCR5 antagonist, INC9471, appears potent, well tolerated after 14 days monotherapy

IAS: Aciclovir treatment doesn't significantly reduce HIV or HSV-2 shedding in genital secretions

IAS: Vicriviroc still effective at 48 weeks in treatment-experienced, but relationship with cancer remains uncertain

IAS: ART interruption particularly unsafe for HIV-positive patients coinfected with hepatitis B or C

IAS: Low rates of HIV transmission in breastfeeding women on ART

IAS: Circumcision may be acceptable to some gay men, but study says no value for HIV prevention

IAS: Screening for B*5701 reduces abacavir hypersensitivity incidence to zero

IAS: Models predict costs and benefits of circumcision programmes

IAS: Penile washing after sex not a substitute for circumcision

IAS: Regular dietician consultation effective at preventing HAART-associated dyslipidaemia

IAS: Cardiovascular disease and diabetes increasing as causes of death for people with HIV in Brazil

Receive the latest HIV research and conference news